Results 101 to 110 of about 4,851,513 (185)

Antistreptolysin O Levels in Patients with Behcet’s Disease

Eurasian Journal of Medicine, 2011
Objective: Behcet’s disease is a multisystem inflammatory disorder, and its etiology has not been defined clearly yet. In this study, we aimed to investigate the antistreptolysin O (ASO) levels of patients with Behcet’s disease.
Hulya Uzkeser, Saliha Karatay, Kadir Yildirim, Ali Karakuzu, Muhammed Hamidullah Uyanik   +4 more
doaj  

A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases

Arthritis &Rheumatology, Volume 78, Issue 9, Page 1961-1974, September 2026.
Objective The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult‐onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory ...
Yvonne M. Mueller, Charlotte Girard, Harmen J. G. van de Werken, Stefan J. Erkeland, Dwin G. B. Grashof, Laurie Vaillant, Renske J. H. den Dekker, Iris van Zuijen, Sharon Veenbergen, Fanny Coffin, Eric Bindels, Yvan Jamilloux, Katerina Laskari, Vassili Soumelis, Bruno Fautrel, Cem Gabay, Peter D. Katsikis   +16 more
wiley   +1 more source

Color Doppler Ultrasound in Ocular Behçet's Disease

, 1997
The purpose of this study was to evaluate the hemodynamic changes occurring in the ophthalmic vasculature of eyes with Behçet's disease in a controlled clinical trial.
O. Özdemir, S. Altan, O. Uçakhan, M. Salih   +3 more
core   +1 more source

Intracranial arterial aneurysm complicating Behçet's disease

, 1996
PubMedID: 8738367Behçet's disease, a rare condition in central Europe but more common in Turkey where it was originally described, is characterized clinically by the presence of a diagnostic triad of oral and genital aphthous ulcers, meningitis, and ...
Tuna M., Göçer A.I., Iidan F., Karadayi A., Bagdatoglu H.   +4 more
core   +1 more source

Staged Endovascular Intervention for Axillary Artery Aneurysm Complicated by Recurrent Upper Limb Arterial Embolism: A Case Report

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Axillary artery aneurysm is an uncommon subtype of peripheral arterial aneurysm, and mural thrombus within the aneurysm sac frequently dislodges to trigger recurrent refractory acute upper extremity arterial embolism. This study reports a 57‐year‐old male patient who suffered immediate re‐embolization after isolated percutaneous thrombus ...
Xiaolong Li, Yayun Xiao, Yulin Zhang, Liwei Zhang, Qunfeng Liu   +4 more
wiley   +1 more source

Spinal Cord Sarcoidosis Treated With Infliximab

Clinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Isolated spinal cord lesion could be misinterpreted as a demyelinating disease. The diagnosis of sarcoidosis should be in the differential when other indices for a demyelinating disorder are absent. An inadequate response to intravenous steroid therapy should not rule out spinal sarcoidosis as this report confirms the response to intravenous ...
Hussein Moussa, Roula Hourani Rizk, Nina S. Shabb, Nabil El Ayoubi, Raja Sawaya   +4 more
wiley   +1 more source

Management of Refractory and Difficult‐To‐Treat Inflammatory Bowel Disease: An Expert Opinion Review

JCC Plus, Volume 1, Issue 5, September 2026.
This expert opinion offers a practical framework for refractory and difficult‐to‐treat IBD: confirm inflammation objectively, distinguish pharmacologic from structural and functional disease, and then escalate. Across ten clinical questions, the evidence is often limited to case series, and the resulting statements are identified as expert opinion ...
Filiz Akyuz, Oguz Kagan Bakkaloglu, Nalan Gulsen Unal, Ismail Hakki Kalkan, Mehmet Arhan, Ibrahim Hatemi, Taylan Kav, Murat Toruner, Hale Akpinar, Ahmet Tezel, Aykut Ferhat Celik   +10 more
wiley   +1 more source

Adalimumab for sight-threatening uveitis in Behçet's disease

, 2006
AIMS: To describe the clinical outcome of three patients with Behçet's disease maintained on infliximab who were switched to adalimumab therapy. METHODS: Case note review. Main outcome measure was recurrence of uveitis.
Situnayake, Rohan, Murray, Philip; id_orcid, Mushtaq, B, Saeed, T   +3 more
core   +1 more source

Bimekizumab 2‐year efficacy by hidradenitis suppurativa duration: BE HEARD EXT results

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Raj Chovatiya, Afsaneh Alavi, Takuya Miyagawa, Irina Turchin, Thrasyvoulos Tzellos, Hessel H. van der Zee, Christina Crater, Bartosz Lukowski, Nicola Tilt, Christos C. Zouboulis   +9 more
wiley   +1 more source

When to consider an inborn error of immunity: clues for physicians

Internal Medicine Journal, Volume 56, Issue 9, Page 1488-1499, September 2026.
Abstract The term inborn errors of immunity (IEIs) refers to the rapidly expanding group of genetic disorders causing dysregulation of the immune system. With improved genetic testing in recent years, the number of defined IEIs and their range of phenotypic presentations has grown vastly, with more than 550 IEIs now described.
Meera Thangarajah, Lucinda J. Berglund
wiley   +1 more source